Article Details

Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in ...

Retrieved on: 2021-03-15 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in .... View article details on hiswai:

Excerpt

RTX-240 Generated Partial Responses in Metastatic Anal Cancer and ... RTX-240 is expected to broadly stimulate the immune system by activating ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up